SMAD4 and pancreatic neoplasm: In pancreatic cancer, Runx3 expression levels were dependent on Smad4 expression—high Runx3 expression, in the presence of Smad4 inactivation, Kras and p53 oncogenic mutations, correlated with metastatic potential (13).